Healthcare provider profile · identity verified

Jothis C Jose, M.D.

Family Practice · OAK CREEK, WI · NPI 1306130737

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	676	190
Losartan Potassium	Losartan Potassium	423	105
Lisinopril	Lisinopril	266	67
Amlodipine Besylate	Amlodipine Besylate	262	72
Pantoprazole Sodium	Pantoprazole Sodium	240	67
Gabapentin	Gabapentin	223	52
Omeprazole	Omeprazole	221	54
Levothyroxine Sodium	Levothyroxine Sodium	210	58
Metoprolol Succinate	Metoprolol Succinate	207	58
Metformin Hcl	Metformin Hcl	199	55
Albuterol Sulfate Hfa	Albuterol Sulfate	183	57
Rosuvastatin Calcium	Rosuvastatin Calcium	154	54
Hydrochlorothiazide	Hydrochlorothiazide	153	46
Fluticasone Propionate	Fluticasone Propionate	151	52
Metformin Hcl Er	Metformin Hcl	151	40
Furosemide	Furosemide	140	35
Metoprolol Tartrate	Metoprolol Tartrate	127	34
Tamsulosin Hcl	Tamsulosin Hcl	122	30
Simvastatin	Simvastatin	119	29
Tizanidine Hcl	Tizanidine Hcl	112	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	98	19
Pravastatin Sodium	Pravastatin Sodium	98	28
Escitalopram Oxalate	Escitalopram Oxalate	88	22
Ozempic	Semaglutide	82	13
Sertraline Hcl	Sertraline Hcl	82	23
Eliquis	Apixaban	81	21
Clonazepam	Clonazepam	73	11
Zolpidem Tartrate	Zolpidem Tartrate	72	14
Potassium Chloride	Potassium Chloride	68	16
Jardiance	Empagliflozin	66	14
Allopurinol	Allopurinol	65	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	65	19
Clopidogrel	Clopidogrel Bisulfate	64	15
Duloxetine Hcl	Duloxetine Hcl	60	15
Glimepiride	Glimepiride	60	16
Carvedilol	Carvedilol	58	14
Montelukast Sodium	Montelukast Sodium	57	16
Trulicity	Dulaglutide	57	suppressed
Citalopram Hbr	Citalopram Hydrobromide	56	13
Trazodone Hcl	Trazodone Hcl	54	19
Farxiga	Dapagliflozin Propanediol	45	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	suppressed
Hydralazine Hcl	Hydralazine Hcl	43	11
Triamcinolone Acetonide	Triamcinolone Acetonide	43	19
Ezetimibe	Ezetimibe	42	15
Spironolactone	Spironolactone	41	suppressed
Donepezil Hcl	Donepezil Hcl	40	suppressed
Pregabalin	Pregabalin	40	suppressed
Alendronate Sodium	Alendronate Sodium	38	suppressed
Alprazolam	Alprazolam	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Glipizide	Glipizide	37	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Warfarin Sodium	Warfarin Sodium	37	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	11
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Clonidine Hcl	Clonidine Hcl	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	29	suppressed
Glipizide Er	Glipizide	29	suppressed
Primidone	Primidone	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Ketoconazole	Ketoconazole	26	16
Meloxicam	Meloxicam	26	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	21
Prednisone	Prednisone	25	24
Famotidine	Famotidine	24	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	12
Latanoprost	Latanoprost	23	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	11
Lorazepam	Lorazepam	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	17
Meclizine Hcl	Meclizine Hcl	19	11
Phenytoin	Phenytoin	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Lactulose	Lactulose	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Cephalexin	Cephalexin	15	11
Sucralfate	Sucralfate	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Valsartan	Valsartan	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Methylprednisolone	Methylprednisolone	13	13
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	13
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Atenolol	Atenolol	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Diazepam	Diazepam	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Trifluoperazine Hcl	Trifluoperazine Hcl	12	suppressed
Azithromycin	Azithromycin	11	11
Gemfibrozil	Gemfibrozil	11	suppressed
Pen Needle	Pen Needle, Diabetic	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Selenium Sulfide	Selenium Sulfide	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error